Neoadjuvant regimen for patients with ovarian cancer #SGOmtg
Thomas Herzog, MD of UC Health discusses neoadjuvant regimen for patients with ovarian cancer at SGO 2016.
Author: sgo2016
Added: 03/24/2016 (Source: Oncology Tube)
Source: Oncology Tube - March 24, 2016 Category: Cancer & Oncology Source Type: podcasts
Age and the decision to use intraperitoneal chemotherapy in ovarian cancer #SGOmtg
Thomas Herzog, MD of UC Health discusses age and the decision to use intraperitoneal chemotherapy in ovarian cancer at SGO 2016.
Author: sgo2016
Added: 03/23/2016 (Source: Oncology Tube)
Source: Oncology Tube - March 24, 2016 Category: Cancer & Oncology Source Type: podcasts
Ovarian cancer is targetable with PARP inhibitors #SGOMTG
Michael J. Birrer, MD of Dana-Farber discusses ovarian cancer is targetable with PARP inhibitors at SGO 2016.
Author: sgo2016
Added: 03/23/2016 (Source: Oncology Tube)
Source: Oncology Tube - March 23, 2016 Category: Cancer & Oncology Source Type: podcasts
Multiplex testing and next generation sequencing in metastatic ovarian cancer #SGOMTG
Michael J. Birrer, MD of Dana-Farber discusses multiplex testing and next generation sequencing in metastatic ovarian cancer at SGO 2016.
Author: sgo2016
Added: 03/23/2016 (Source: Oncology Tube)
Source: Oncology Tube - March 23, 2016 Category: Cancer & Oncology Source Type: podcasts
Current actionable mutations in advanced ovarian cancer #SGOmtg
Michael J. Birrer, MD of Dana-Farber discusses current actionable mutations in advanced ovarian cancer at SGO 2016.
Author: sgo2016
Added: 03/23/2016 (Source: Oncology Tube)
Source: Oncology Tube - March 23, 2016 Category: Cancer & Oncology Source Type: podcasts
Vice President Biden’s initiative to increase clinical trials for women with ovarian cancer
Elizabeth Swisher MD of the University Of Washington discusses Vice President Biden’s initiative to increase clinical trials for women with ovarian cancer at SGO 2016.
Author: sgo2016
Added: 03/22/2016 (Source: Oncology Tube)
Source: Oncology Tube - March 22, 2016 Category: Cancer & Oncology Source Type: podcasts
Using Next Generation Genetic Sequencing to determine what fraction of ovarian cancer are caused by heredity
Elizabeth Swisher MD of the University Of Washington discusses using Next Generation Genetic Sequencing to determine what fraction of ovarian cancer are caused by heredity at SGO 2016.
Author: sgo2016
Added: 03/22/2016 (Source: Oncology Tube)
Source: Oncology Tube - March 22, 2016 Category: Cancer & Oncology Source Type: podcasts
Ovarian cancer focus for 2016 to include genetic analysis and target therapies
Elizabeth Swisher MD of the University Of Washington discusses ovarian cancer focus for 2016 to include genetic analysis and target therapies at SGO 2016.
Author: sgo2016
Added: 03/22/2016 (Source: Oncology Tube)
Source: Oncology Tube - March 22, 2016 Category: Cancer & Oncology Source Type: podcasts
Genomic analysis may improve prevention, screening and management of inherited ovarian cancer
Elizabeth Swisher MD of the University Of Washington discusses how genomic analysis may improve prevention, screening and management of inherited ovarian cancer at SGO 2016.
Author: sgo2016
Added: 03/22/2016 (Source: Oncology Tube)
Source: Oncology Tube - March 22, 2016 Category: Cancer & Oncology Source Type: podcasts
#378 : keynotes to life
At the height of her career, as an Air Force Colonel and physicist Deanna Won was diagnosed with ovarian cancer and was given one month to live. Deanna Joins us to discuss her strong passion for providing help to those who seek to heal in mind, body, and spirit and leading a life of purpose. Survivor spotlight on Hannah Klitsberg. (Source: The Stupid Cancer Show - Blog Talk Radio)
Source: The Stupid Cancer Show - Blog Talk Radio - March 22, 2016 Category: Cancer & Oncology Authors: Stupid Cancer Show Tags: Health Source Type: podcasts
Olaparib and bevacizumab: On the horizon for treating ovarian cancer
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Suresh Kumarasamy, MBBS(Mysore), MObGyn(Mal), FRCOG(Lond), FRCP(Ire), AM...
Author: EMJ
Added: 02/18/2016 (Source: Oncology Tube)
Source: Oncology Tube - February 18, 2016 Category: Cancer & Oncology Source Type: podcasts
ESMO 2015 highlights: Putting ovarian cancer management into perspective
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Andrés Cervantes, MD, PhD, from the University of Valencia, Valencia, Sp...
Author: EMJ
Added: 02/02/2016 (Source: Oncology Tube)
Source: Oncology Tube - February 2, 2016 Category: Cancer & Oncology Source Type: podcasts
Olaparib: Opportunity for personalised medicine in ovarian cancer
Recently, there have been numerous advances in the biological understanding of ovarian cancer. At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 Decembe...
Author: EMJ
Added: 01/30/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 30, 2016 Category: Cancer & Oncology Source Type: podcasts
Ovarian cancer: Future outlook, promising trials, new treatments
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Prof Jonathan A. Ledermann, from UCL Cancer Institute and UCL Hospitals,...
Author: PatientPowerEU
Added: 01/30/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 30, 2016 Category: Cancer & Oncology Source Type: podcasts
